Unitedhealth Group INC Form 4 insider transactions

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options on February 20 and 21, 2025.

Andrew Witty, CEO of UnitedHealth Group, reports acquisition and disposal of common stock and non-qualified stock options.

Timothy Noel, Chief Executive Officer of UHC, reports acquisition and disposal of UnitedHealth Group [UNH] common stock and stock options on February 20-21, 2025.

John F. Rex, President & CFO of UnitedHealth Group, reported the disposal of 799.133 shares of common stock on February 14, 2025, at a price of $523.51.

Heather Cianfrocco, Chief Executive Officer of Optum, reports the disposal of UnitedHealth Group common stock to cover tax obligations.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports a transaction involving common stock on February 14, 2025.

Timothy Noel, Chief Executive Officer of UHC, reports the disposal of common stock in UnitedHealth Group on February 14, 2025.

Andrew Witty, CEO of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports a transaction involving common stock on February 14, 2025.

Erin McSweeney, EVP & Chief People Officer of UnitedHealth Group, reports the disposal of common stock to cover tax obligations.

John F. Rex, President & CFO of UnitedHealth Group, reports exercising stock options and disposing of shares to cover taxes.

Director Timothy Flynn of UnitedHealth Group Incorporated (UNH) purchased 1,000 shares of common stock at $511.575 per share on January 17, 2025.

Director Charles D. Baker acquired 174 shares of UnitedHealth Group common stock as part of his quarterly compensation.

Frederick William McNabb III, a director at UnitedHealth Group, acquired 190 shares of common stock as deferred compensation on January 2, 2025.

Director Kristen Gil of UnitedHealth Group reported acquiring 112 deferred stock units and 62 shares of common stock as part of her quarterly compensation.

A director at UnitedHealth Group has been granted deferred stock units as part of their regular quarterly compensation.

A UnitedHealth Group director, John H. Noseworthy, acquired 186 shares of common stock as part of his quarterly compensation.

Timothy Patrick Flynn, a director at UnitedHealth Group, acquired 186 shares of common stock through deferred stock units as part of his quarterly compensation.

Director Paul R. Garcia of UnitedHealth Group reported acquiring 174 shares of common stock and deferred stock units as part of regular quarterly compensation.

Director Stephen J. Hemsley of UnitedHealth Group reported the acquisition of 283 deferred stock units and indirect ownership of common stock through various accounts.

Valerie Montgomery Rice, a director at UnitedHealth Group, acquired 186 shares of common stock as part of her quarterly compensation.

Director John H. Noseworthy reports acquiring 24 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Andrew Witty, CEO of UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents on restricted stock units.

Erin McSweeney, EVP & Chief People Officer at UnitedHealth Group, reports acquisition and disposal of common stock due to dividend equivalents paid on restricted stock units.

Heather Cianfrocco, Chief Executive Officer of Optum, reports the acquisition of dividend equivalents on restricted stock units of UnitedHealth Group.

Stephen J. Hemsley, a director at UnitedHealth Group, filed a Form 4 disclosing the acquisition of shares through dividend equivalents and a gift of shares.

Christopher R. Zaetta, EVP & Chief Legal Officer of UnitedHealth Group, reports acquisition of common stock through dividend equivalents.

John F. Rex, President & CFO of UnitedHealth Group, reports acquisition and disposal of common stock and dividend equivalents related to restricted stock units.

Director Charles D. Baker reports acquiring 3 shares of UnitedHealth Group common stock due to dividend equivalents paid on vested deferred stock units.

Thomas E. Roos, Chief Accounting Officer of UnitedHealth Group, reports acquisition of common stock due to dividend equivalents paid on restricted stock units.